ALEXANDRIA, Va., June 19 -- United States Patent no. 12,331,018, issued on June 17, was assigned to Merck Sharp & Dohme LLC (Rahway, N.J.).
"Pyrrolidine orexin receptor agonists" was invented by Stephane L. Bogen (Somerset, N.J.), Michael J. Breslin (Drexel Hill, Pa.), Dane James Clausen (Rahway, N.J.), Anthony Ginnetti (Perkasie, Pa.), Michael T. Rudd (Collegeville, Pa.), Shawn J. Stachel (Perkasie, Pa.), Craig A. Stump (Pottstown, Pa.) and Dexi Yang (Livingston, N.J.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention is directed to pyrrolidine compounds which are agonists of orexin receptors. The present invention is also directed to uses of the compounds described herein in the potential...